Clinical Trials in Dementia
Fellowship Available July 1, 2013
Toronto Memory Program is now accepting applicants for the new Pfizer-Alzheimer Society of Ontario Dementia Trial Investigator Fellowship to commence July 1, 2013. This one year fellowship was created to address the need for qualified investigators in the field of clinical pharmacological research in dementia and will be of interest to those who want to be involved in advancing treatment options for this disease. . The successful applicant will acquire the knowledge and practical experience in dementia research and dementia practice to act as Principal Investigator at an independent trial site. The fellowship takes place at Toronto Memory Program, Canada’s most active dementia clinical pharmacological research site. Supervisor: Dr. Sharon Cohen, PI and Behavioural Neurologist.
The fellowship curriculum involves hands on experience with issues related to research practice as well as dementia clinical practice, including but not limited to:
· Research regulations
· Principal Investigator responsibilities
· Study designs and protocol review
· Trial budgets and contracts
· Study start up activities
· Research visits; clinical trial operations
· Standard Operating Procedures
· Industry relations
· Audit preparation
· Clinical and research diagnostic criteria
· Standard of care in dementia treatment
Applications will be accepted from:
Physicians qualified to practice medicine in Ontario and trained in any of the following: Neurology, geriatrics, psychiatry, family medicine,.
Interested applicants should send:
· A letter of intent detailing your interest in the current fellowship and describing your future practice plans
· An up-to-date CV signed and dated at the bottom of each page
· Contact information for three individuals who could provide references on your behalf
Applications will remain confidential and can be sent by post to:
Dr. Sharon Cohen, Toronto Memory Program, 1 Valleybrook Dr,. Suite 400
Toronto, ON M3B 2S7
Or by email to: